.

Recently added

LAUR Repository

SOP - Scholarly Publications: Recent submissions

  • Abdallah, Jad; Malki, Abderrahim; Caldas, Therese; Kern, Renee; Eckey, Viola; Kim, So Jung; Cha, Sun-Shin; Mori, Hirotada; Richard, Richarme; SOP; 200703820; N/A; jabdallah@lau.edu.lb
    Hsp31, the Escherichia coli hcha gene product, is a molecular chaperone whose activity is inhibited by ATP at high temperature. Its crystal structure reveals a putative Cys184, His185, and Asp213 catalytic triad similar ...
  • Sheikh-Taha, Marwan; SOP; 199410150; Pharmacy Practice Department; marwan.taha@lau.edu.lb
    Background: In patients with acutely decompensated heart failure (HF), intravenous infusion of nesiritide improves hemodynamics and symptoms with few adverse effects. We investigated the tolerability as well as efficacy ...
  • Sheikh-Taha, Marwan; Eiland, Edward; Han, Jian; Lindgren, Willliam; Macandrew English, Thomas; Hassoun, Ali; SOP; 199410150; Pharmacy Practice Department; marwan.taha@lau.edu.lb
    Background: The emergence of novel swine-origin influenza A (H1N1) virus (S-OIV) infection represents a significant pandemic threat. Rapid and accurate diagnosis will enhance treatment and containment efforts. Methods: ...
  • Sheikh-Taha, Marwan; SOP; 199410150; Pharmacy Practice Department; marwan.taha@lau.edu.lb
    AIM: To assess the appropriateness of prescribing acid suppressive therapy (AST) in a general medicine service in a tertiary care hospital. METHODS: In this retrospective observational study, we reviewed the inpatient ...
  • Sheikh-Taha, Marwan; Frenn, Pascale; SOP; 199410150; Pharmacy Practice Department; marwan.taha@lau.edu.lb
    Drug-induced autoimmune hemolytic anemia is a rare condition. We report the case of a 32-year-old white female who presented to the emergency department with generalized fatigue, fever, and jaundice. The patient reported ...
  • Sheikh-Taha, Marwan; Khoury, Ghada; SOP; 199410150; 200104046; Pharmacy Practice Department; marwan.taha@lau.edu.lb; ghada.khoury@lau.edu.lb
    Objective We examined the potential effect of sex and age on warfarin dosing in ambulatory adult patients. Methods We conducted a retrospective chart review of patients attending an anticoagulation clinic. We ...
  • Sheikh-Taha, Marwan; Strickland, Warren; SOP; 199410150; Pharmacy Practice Department; marwan.taha@lau.edu.lb
    Background: Abrupt closure and restenosis remain serious and costly consequences of coronary angioplasty procedures. Eptifibatide (Integrilin) has been shown to decrease the rate of combined endpoint of death, new myocardial ...
  • Sheikh-Taha, Marwan; SOP; 199410150; Pharmacy Practice Department; marwan.taha@lau.edu.lb
    Details the administration of intermittent nesiritide therapy in outpatients with chronic heart failure in the U.S. Tolerance of the drug; Observation of decreased hospital admissions; Identification of hypotension the ...
  • Sheikh-Taha, Marwan; Ghosn, Samer; SOP; 199410150; Pharmacy Practice Department; marwan.taha@lau.edu.lb
    Background: Anticoagulation therapy during percutaneous coronary intervention (PCI) has been the focus of numerous clinical trials. Low-anticoagulant doses have been successfully used in patients undergoing elective PCI, ...
  • Sheikh-Taha, Marwan; SOP; 199410150; Pharmacy Practice Department; marwan.taha@lau.edu.lb
  • Sheikh-Taha, Marwan; Awar, Zeina; SOP; 199410150; Pharmacy Practice Department; marwan.taha@lau.edu.lb
    Venous thromboembolism is a common complication and a major cause of morbidity and mortality in cancer patients. Patients with malignancies have a four-fold greater risk of venous thromboembolism compared with patients ...
  • Sheikh-Taha, Marwan; SOP; 199410150; Pharmacy Practice Department; marwan.taha@lau.edu.lb
  • Sheikh-Taha, Marwan; Zeitoun, Abeer; SOP; 199410150; Pharmacy Practice Department; marwan.taha@lau.edu.lb
  • Sheikh-Taha, Marwan; Koussa, Suzanne; Inati, Adlette; Taher, Ali; SOP; 199410150; Pharmacy Practice Department; marwan.taha@lau.edu.lb
    A 36-year-old transfusion-dependent thalassemia major patient presented with febrile neutropenia and anemia. Deferiprone (L1) was discontinued as it was suspected to be the offending agent and prompt broad-spectrum antibiotic ...
  • Sheikh-Taha, Marwan; Sabbagh, Racha; SOP; 199410150; Pharmacy Practice Department; marwan.taha@lau.edu.lb
    Purpose. A possible case of montelukast-induced angioedema is reported. Summary. A 46-year-old woman with a history of severe allergies, including food allergies, and angioedema was evaluated at the emergency department ...
  • Sheikh-Taha, Marwan; Taher, Ali; SOP; 199410150; Pharmacy Practice Department; marwan.taha@lau.edu.lb
    We read with great interest the recent paper by Karimi et al 1 describing the safety and efficacy of hydroxyurea (HU) in reducing complications of extramedullary hemopoiesis as well as increasing Hb levels in Iranian ...
  • Sheikh-Taha, Marwan; Inati, Adlette; Musallam, Khaled; Wood, John; Daou, Linda; Taher, Ali; SOP; 199410150; Pharmacy Practice Department; marwan.taha@lau.edu.lb
    Background:  The use of magnetic resonance imaging (MRI) to detect organ-specific iron overload is becoming increasingly common. Although hepatic iron overload has been recognized in patients with sickle cell disease (SCD), ...
  • Sheikh-Taha, Marwan; Taher, A.; Inati, A.; Ellis, G.; Dhillon, A.P.; Hoffbrand, A.V.; SOP; 199410150; Pharmacy Practice Department; marwan.taha@lau.edu.lb
    Deferiprone at a dose of 75 mg/kg/day is not sufficiently effective to maintain iron stores at a level which has been considered safe in all patients with iron overload. Our main aim was to determine the safety of long-term ...
  • Sheikh-Taha, Marwan; Taher, Ali; Koussa, Suzanne; Inati, Adlette; Neeman, Roger; Mourad, Fadi; SOP; 199410150; Pharmacy Practice Department; marwan.taha@lau.edu.lb
    Abstract: Introduction: Iron-chelating therapy with deferoxamine in patients with thalassemia major has dramatically improved the prognosis of this disease. However, the limitations of this treatment have stimulated the ...
  • Sheikh-Taha, Marwan; Mourad, Fadi; Hoffbrand, Victor; Koussa, Susane; Khoriaty, Adlette; Taher, Ali; SOP; 199410150; Pharmacy Practice Department; marwan.taha@lau.edu.lb
    Summary. Desferrioxamine (DFX) alone (40–50 mg/kg/d s.c. over 8–12 h, five times weekly) was compared with combined DFX twice weekly and deferiprone (75 mg/kg/d) over 12 months in previously poorly chelated thalassaemia ...

Search LAUR


Advanced Search

Browse

My Account